Results 171 to 180 of about 4,527,439 (244)

Patch Testing Is Useful in Patients With Lamotrigine‐Induced Cutaneous Adverse Drug Reactions

open access: yes
Contact Dermatitis, EarlyView.
E. Bertazzo   +4 more
wiley   +1 more source

Ropeginterferon‐α2b in mycosis fungoides and Sézary syndrome: Safety and efficacy in 41 patients

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Pegylated interferon‐α2a became the off‐label alternative for treating mycosis fungoides/Sézary syndrome (MF/SS) after non‐pegylated interferons were withdrawn. This study aimed to evaluate the safety and efficacy of ropeginterferon‐α2b in MF/SS. Patients and methods We performed a retrospective multicenter analysis at
Stefanie Porkert   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy